Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medodermone 0.05% w/w cream.
| Pharmaceutical Form |
|---|
|
Cream. White, soft, homogeneous, smooth, odourless cream. |
Each 1 g of cream contains 0.5mg clobetasol propionate.
Excipients with known effect: cetostearyl alcohol, methyl-p-hydroxybenzoate and propyl-p-hydroxybenzoate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clobetasol propionate |
Clobetasol propionate, like other topical corticosteroids, has anti-inflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. |
| List of Excipients |
|---|
|
Liquid paraffin |
PVC screwed-cap pilferproof aluminium tubes of 15 g and 25 g.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
19980
Date of first authorization: 20/12/2005
Date of latest renewal: 24/05/2017
| Drug | Countries | |
|---|---|---|
| MEDODERMONE | Cyprus, Hong Kong, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
